×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Cervical Cancer
Jessica Skarzynski
Here is a list of clinical trials that are currently happening within the cervical cancer space.
Katie Kosko
Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.
Tom Castles
A new study suggests distributing self-testing kits by mail helps bring effective testing to underserved populations and makes it easier for women to get tested on their own time.
Tom Castles
Results from a new study suggest there may be a simpler, cheaper, more accessible way to screen for cervical pre-cancer.
Katie Kosko
Researchers from Yale Cancer Center have created a platform to identify genetic mutations that might drive cervical cancer.
Katie Kosko
Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.
Katie Kosko
Patients with recurrent or metastatic cervical cancer were treated with combination Opdivo and Yervoy in the CheckMate-358 clinical trial.
Stephanie Fraser, M.S.W.
A essay nominating Kimberly Spina, B.S.N., RN for CURE®’s Extraordinary Healer® Award, written by Stephanie Fraser, M.S.W., of The University of Vermont Cancer Center.
Jessica Skarzynski
Here are the top 5 CURE stories for January 2019.
Katie Kosko
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.